Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moleculin Biotech (MBRX) Non-cash Items (2023 - 2025)

Moleculin Biotech (MBRX) has 2 years of Non-cash Items data on record, last reported at $378606.0 in Q4 2023.

  • For Q4 2023, Non-cash Items changed N/A year-over-year to $378606.0; the TTM value through Dec 2023 reached $378606.0, changed N/A, while the annual FY2023 figure was $93337.0, N/A changed from the prior year.
  • Non-cash Items reached $378606.0 in Q4 2023 per MBRX's latest filing, down from $2.0 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $2.0 million in Q3 2020 and bottomed at $378606.0 in Q4 2023.